KOLMAR KOREA CO., LTD - Company Intelligence Brief

1. Business Overview

[TRANSLATION NOTE] Kolmar Korea operates as a leading Original Development and Manufacturing (ODM) company in the Korean cosmetics and pharmaceutical sectors. The company provides end-to-end manufacturing solutions including research and development, formulation, production, and packaging for major beauty and health brands. Based on the consolidated financial statement filings, Kolmar Korea maintains significant fixed asset investments (non-current assets of KRW 2,268 billion as of December 2024), suggesting substantial manufacturing infrastructure to support its ODM business model.

2. Financial Trend

Kolmar Korea demonstrates strong revenue momentum with sales reaching KRW 2,452 billion in 2024, representing a 13.8% year-over-year increase from KRW 2,156 billion in 2023 and a remarkable 31.4% growth from KRW 1,866 billion in 2022.

Operating profitability has improved substantially, with operating profit of KRW 193.9 billion in 2024 (7.9% margin), up 42.4% from KRW 136.1 billion in 2023 (6.3% margin) and more than double the KRW 73.3 billion recorded in 2022. Net income surged to KRW 125.3 billion in 2024, nearly five times the KRW 25.1 billion reported in 2023, following a loss of KRW 4.1 billion in 2022.

Total liabilities stood at KRW 1,621 billion as of December 2024, representing a debt-to-equity ratio of 1.08x (liabilities of KRW 1,621 billion against equity of KRW 1,506 billion). While debt levels increased slightly from KRW 1,591 billion in 2023, retained earnings grew healthily from KRW 367.6 billion to KRW 487.9 billion, indicating improving financial flexibility.

3. Ownership Structure

[TRANSLATION NOTE] Specific ownership structure and foreign ownership percentage data are not provided in the submitted financial statement extracts. The capital stock increased from KRW 11.44 billion (2023) to KRW 11.80 billion (2024), suggesting minor equity issuance or stock-based compensation during the year. Detailed shareholder information would require separate corporate governance filings.

4. Key Risks

Asset-Heavy Business Model Risk: With non-current assets of KRW 2,268 billion representing 72.5% of total assets (KRW 3,127 billion), Kolmar Korea maintains significant fixed capital commitments. This creates operational leverage risk if demand from key ODM clients declines or if excess capacity emerges.

Client Concentration Vulnerability: As an ODM manufacturer, the company likely faces concentration risk tied to major cosmetics and pharmaceutical clients. The revenue surge of 31.4% over two years may reflect temporary market share gains or specific client wins that could prove non-recurring if client preferences shift or in-sourcing decisions occur.

5. Investment Consideration

Kolmar Korea presents a turnaround story with accelerating revenue growth and improving margins in the cosmetics ODM sector, though investors should assess client diversification and capacity utilization sustainability given the asset-intensive business model and volatile three-year earnings trajectory.